RIVASTIGMINE TARTRATE

RIVASTIGMINE TARTRATE was reported 465 times

RIVASTIGMINE TARTRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FOSTER CARE 1 0.0909
1 DUODENAL VARICES 1 0.0417
2 POSTICTAL HEADACHE 1 0.0333
3 ANTICHOLINERGIC SYNDROME 42 0.0263
4 MEDICAL DEVICE SITE MASS 1 0.0244
5 CEREBRAL ATAXIA 1 0.0227
6 CRYPTOGENIC CIRRHOSIS 2 0.0206
7 MEDICAL DEVICE SITE SCAB 1 0.0137
8 STIFF TONGUE 1 0.0123
9 DOLICHOCOLON 1 0.0122
10 MINI MENTAL STATUS EXAMINATION ABNORMAL 1 0.0122
11 HYPNOPOMPIC HALLUCINATION 1 0.0081
12 BLADDER SPHINCTER ATONY 1 0.0065
13 OPEN GLOBE INJURY 1 0.0061
14 MULTIPLE SYSTEM ATROPHY 2 0.0057
15 PLEUROTHOTONUS 5 0.0055
16 SUPINE HYPERTENSION 1 0.0053
17 PARKINSONIAN REST TREMOR 1 0.0053
18 SKIN PRESSURE MARK 1 0.0047
19 HALLUCINATION, OLFACTORY 2 0.0046
20 AGNOSIA 1 0.0042
21 CAMPTOCORMIA 1 0.0042
22 ABDOMINAL WALL HAEMORRHAGE 1 0.0038
23 BLOOD CHOLINESTERASE DECREASED 1 0.0036
24 ENCEPHALOMALACIA 2 0.0036
25 PORTAL HYPERTENSIVE GASTROPATHY 2 0.0035
26 AVERSION 1 0.0035
27 ASPIRATION BRONCHIAL 1 0.0034
28 BUTTOCK INJURY 1 0.0033
29 INCARCERATED HERNIA 1 0.0032
30 PARKINSONIAN GAIT 2 0.0032
31 BRADYARRHYTHMIA 5 0.0030
32 SALIVA DISCOLOURATION 1 0.0030
33 PNEUMONITIS ASPIRATION 1 0.0029
34 RADIAL NERVE PALSY 1 0.0028
35 GLASGOW COMA SCALE ABNORMAL 1 0.0027
36 STOMA SITE EXTRAVASATION 1 0.0026
37 POVERTY OF SPEECH 1 0.0026
38 EYELID FUNCTION DISORDER 2 0.0025
39 PANCREATOLITHIASIS 1 0.0025
40 COMPULSIVE SEXUAL BEHAVIOUR 2 0.0025
41 SYSTOLIC HYPERTENSION 1 0.0023
42 OESOPHAGEAL DILATATION 1 0.0023
43 EPIDERMOLYSIS 1 0.0022
44 DYSPHASIA 1 0.0021
45 PRERENAL FAILURE 3 0.0021
46 PULPITIS DENTAL 2 0.0021
47 PATIENT UNCOOPERATIVE 1 0.0021
48 INFUSION SITE HAEMATOMA 1 0.0021
49 NODAL RHYTHM 3 0.0020
50 SALIVARY GLAND CANCER 1 0.0020
51 CEREBRAL ARTERY THROMBOSIS 1 0.0019
52 BLAST CELL COUNT INCREASED 2 0.0019
53 COGWHEEL RIGIDITY 2 0.0019
54 EXPULSION OF MEDICATION 1 0.0019
55 PERIORBITAL CELLULITIS 1 0.0019
56 STOMA SITE IRRITATION 1 0.0018
57 DEMENTIA WITH LEWY BODIES 2 0.0018
58 DEEP BRAIN STIMULATION 1 0.0017
59 FREEZING PHENOMENON 6 0.0016
60 EXCESSIVE CERUMEN PRODUCTION 1 0.0016
61 STOMA SITE HYPERGRANULATION 1 0.0016
62 CHOLINERGIC SYNDROME 1 0.0016
63 HALLUCINATION, TACTILE 1 0.0015
64 OESOPHAGITIS ULCERATIVE 1 0.0015
65 INFUSION SITE INFLAMMATION 1 0.0014
66 ANAEMIA MACROCYTIC 3 0.0014
67 NASAL INJURY 1 0.0014
68 DENTAL RESTORATION FAILURE 1 0.0014
69 STOMA SITE PAIN 2 0.0014
70 VITAMIN B COMPLEX DEFICIENCY 1 0.0013
71 LICHENOID KERATOSIS 3 0.0013
72 VEIN COLLAPSE 1 0.0013
73 DEBRIDEMENT 1 0.0013
74 PELVIC MASS 1 0.0012
75 JC VIRUS TEST POSITIVE 1 0.0012
76 PARKINSON'S DISEASE 3 0.0012
77 TONGUE MOVEMENT DISTURBANCE 1 0.0012
78 INTESTINAL PSEUDO-OBSTRUCTION 1 0.0011
79 CEREBELLAR ATROPHY 1 0.0011
80 CERUMEN IMPACTION 1 0.0011
81 STOMA SITE ERYTHEMA 2 0.0011
82 WRONG SCHEDULE 1 0.0010
83 CEREBELLAR ATAXIA 1 0.0010
84 PARKINSONISM 10 0.0010
85 LYMPHADENECTOMY 1 0.0010
86 HYPERAEMIA 2 0.0010
87 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 1 0.0010
88 EAR HAEMORRHAGE 2 0.0010
89 GASTRIC PH DECREASED 1 0.0010
90 DEVICE CONNECTION ISSUE 2 0.0009
91 HEPATIC NEOPLASM MALIGNANT 2 0.0009
92 PRODUCT COMMINGLING 1 0.0009
93 TRAUMATIC HAEMATOMA 1 0.0009
94 INFUSION SITE BRUISING 2 0.0009
95 PERIODONTITIS 2 0.0009
96 POSTURE ABNORMAL 3 0.0009
97 INFUSION SITE MASS 1 0.0009
98 GASTROINTESTINAL ULCER HAEMORRHAGE 1 0.0009
99 HYPORESPONSIVE TO STIMULI 1 0.0009
100 WRONG DOSE 2 0.0008
101 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
102 NEPHRITIS INTERSTITIAL 1 0.0008
103 NOCTURNAL DYSPNOEA 1 0.0008
104 IATROGENIC INJURY 1 0.0008
105 MUCORMYCOSIS 2 0.0008
106 LIP INJURY 1 0.0008
107 CEREBRAL ATROPHY 3 0.0008
108 VITAMIN B12 DEFICIENCY 3 0.0007
109 SIALOADENITIS 1 0.0007
110 STOMA SITE DISCHARGE 2 0.0007
111 NONSPECIFIC REACTION 4 0.0007
112 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
113 EXCESSIVE EYE BLINKING 1 0.0007
114 CONJUNCTIVITIS ALLERGIC 1 0.0007
115 INFUSION SITE INDURATION 1 0.0007
116 HYPERTHERMIA MALIGNANT 1 0.0007
117 INFUSION SITE REACTION 2 0.0007
118 VARICES OESOPHAGEAL 2 0.0007
119 STOMA SITE HAEMORRHAGE 1 0.0006
120 DELUSION 10 0.0006
121 SINUS ARREST 1 0.0006
122 SCREAMING 4 0.0006
123 DEMENTIA ALZHEIMER'S TYPE 1 0.0006
124 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
125 SEIZURE LIKE PHENOMENA 1 0.0006
126 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
127 ILEAL STENOSIS 1 0.0006
128 CARDIAC ABLATION 1 0.0006
129 NASAL OEDEMA 1 0.0006
130 FAECALOMA 3 0.0005
131 SINUS NODE DYSFUNCTION 1 0.0005
132 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 1 0.0005
133 FACE INJURY 2 0.0005
134 MOTION SICKNESS 1 0.0005
135 CONCOMITANT DISEASE PROGRESSION 1 0.0005
136 BRADYKINESIA 3 0.0005
137 UNDERWEIGHT 1 0.0005
138 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
139 MIOSIS 4 0.0005
140 DEVICE RELATED SEPSIS 1 0.0005
141 MOTOR DYSFUNCTION 5 0.0005
142 AKINESIA 1 0.0005
143 SUBILEUS 1 0.0005
144 WALKING DISABILITY 1 0.0005
145 NEUROGENIC BLADDER 1 0.0005
146 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
147 GASTROINTESTINAL ULCER 1 0.0005
148 WHEELCHAIR USER 2 0.0004
149 PARESIS 1 0.0004
150 ANAL INCONTINENCE 4 0.0004
151 CHRONIC GASTRITIS 1 0.0004
152 BLOOD LOSS ANAEMIA 1 0.0004
153 PERIARTHRITIS 1 0.0004
154 HALLUCINATION 33 0.0004
155 PANCREATITIS NECROTISING 1 0.0004
156 DROOLING 3 0.0004
157 HAEMANGIOMA 1 0.0004
158 NEUROLOGICAL DECOMPENSATION 1 0.0004
159 URINARY TRACT OBSTRUCTION 1 0.0004
160 RADIUS FRACTURE 1 0.0004
161 LEARNING DISORDER 1 0.0004
162 ENTEROCOCCAL INFECTION 2 0.0004
163 STARING 1 0.0004
164 HAEMATOLOGICAL INFECTION 1 0.0004
165 SUFFOCATION FEELING 1 0.0004
166 PRESCRIBED UNDERDOSE 8 0.0004
167 GASTROINTESTINAL TUBE INSERTION 1 0.0004
168 VEIN DISORDER 2 0.0004
169 INCREASED BRONCHIAL SECRETION 1 0.0004
170 CEREBRAL ISCHAEMIA 2 0.0004
171 PHYSICAL DECONDITIONING 1 0.0004
172 HEPATITIS TOXIC 1 0.0004
173 CATATONIA 2 0.0004
174 GASTROINTESTINAL STROMAL TUMOUR 1 0.0004
175 PROTEIN TOTAL INCREASED 1 0.0004
176 PRODUCT CLEANING INADEQUATE 1 0.0004
177 AREFLEXIA 1 0.0004
178 EAR CONGESTION 1 0.0004
179 HICCUPS 3 0.0004
180 CLONUS 1 0.0004
181 HEART RATE ABNORMAL 2 0.0004
182 DISORIENTATION 14 0.0004
183 BREAST CANCER STAGE IV 1 0.0004
184 VOMITING PROJECTILE 1 0.0003
185 ORTHOSTATIC HYPOTENSION 6 0.0003
186 THERAPEUTIC REACTION TIME DECREASED 1 0.0003
187 PULMONARY PAIN 1 0.0003
188 DRUG INTERACTION 54 0.0003
189 TOOTH DISCOLOURATION 1 0.0003
190 NEUROLEPTIC MALIGNANT SYNDROME 4 0.0003
191 HEPATITIS FULMINANT 1 0.0003
192 URINE ANALYSIS ABNORMAL 1 0.0003
193 METABOLIC ENCEPHALOPATHY 1 0.0003
194 HYPERCAPNIA 1 0.0003
195 HALLUCINATION, VISUAL 7 0.0003
196 MASTICATION DISORDER 1 0.0003
197 GRAND MAL CONVULSION 3 0.0003
198 SCOLIOSIS 2 0.0003
199 DEMENTIA 9 0.0003
200 HEPATIC ENCEPHALOPATHY 3 0.0003
201 INFUSION SITE SWELLING 2 0.0003
202 FOREIGN BODY IN THROAT 1 0.0003
203 DRUG EFFECT INCREASED 1 0.0003
204 BILE DUCT STONE 1 0.0003
205 VENTRICULAR HYPOKINESIA 1 0.0003
206 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0003
207 HEPATIC NEOPLASM 1 0.0003
208 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
209 LISTLESS 1 0.0003
210 SALIVARY HYPERSECRETION 3 0.0003
211 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
212 POTENTIATING DRUG INTERACTION 1 0.0003
213 WRONG PRODUCT ADMINISTERED 2 0.0003
214 CERVICAL VERTEBRAL FRACTURE 1 0.0003
215 PRODUCT SUPPLY ISSUE 2 0.0003
216 COGNITIVE DISORDER 13 0.0003
217 APPARENT DEATH 1 0.0003
218 SKIN LACERATION 3 0.0003
219 DEVICE KINK 1 0.0003
220 CONFUSIONAL STATE 44 0.0003
221 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
222 ARTHROPOD BITE 2 0.0003
223 SEDATION 7 0.0003
224 IMPULSIVE BEHAVIOUR 1 0.0003
225 SNORING 1 0.0003
226 CATHETER SITE INFECTION 1 0.0003
227 BRADYCARDIA 14 0.0003
228 LOSS OF CONTROL OF LEGS 1 0.0003
229 GASTRIC INFECTION 1 0.0003
230 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
231 REHABILITATION THERAPY 1 0.0003
232 PELVIC FRACTURE 2 0.0003
233 CARDIOPULMONARY FAILURE 1 0.0003
234 HAEMORRHAGIC STROKE 2 0.0003
235 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
236 MYOCLONUS 3 0.0003
237 MUSCLE RIGIDITY 3 0.0003
238 BLEPHARITIS 1 0.0002
239 ORGAN FAILURE 1 0.0002
240 RHINITIS 2 0.0002
241 SELF-MEDICATION 1 0.0002
242 SPINAL STENOSIS 1 0.0002
243 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
244 HALLUCINATIONS, MIXED 1 0.0002
245 SLEEP TERROR 1 0.0002
246 INFUSION SITE ERYTHEMA 2 0.0002
247 PSYCHOTIC DISORDER 7 0.0002
248 BUNDLE BRANCH BLOCK LEFT 1 0.0002
249 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
250 AORTIC VALVE INCOMPETENCE 1 0.0002
251 LUNG NEOPLASM 1 0.0002
252 PRODUCT DISPENSING ISSUE 1 0.0002
253 IMMOBILE 1 0.0002
254 MELANOCYTIC NAEVUS 1 0.0002
255 ONYCHOMYCOSIS 1 0.0002
256 LIGAMENT RUPTURE 1 0.0002
257 RESPIRATORY RATE INCREASED 2 0.0002
258 DYSKINESIA 9 0.0002
259 AGITATION 16 0.0002
260 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
261 SPUTUM DISCOLOURED 2 0.0002
262 APHAGIA 1 0.0002
263 MUCOUS STOOLS 1 0.0002
264 EXTRAPYRAMIDAL DISORDER 5 0.0002
265 AMMONIA INCREASED 1 0.0002
266 FEMORAL NECK FRACTURE 1 0.0002
267 PRODUCT COLOUR ISSUE 1 0.0002
268 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
269 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
270 SENSITIVITY TO WEATHER CHANGE 1 0.0002
271 PHARYNGOLARYNGEAL PAIN 1 0.0002
272 EATING DISORDER 4 0.0002
273 ANAL FISSURE 1 0.0002
274 PRODUCT RESIDUE PRESENT 1 0.0002
275 BIPOLAR DISORDER 2 0.0002
276 PULMONARY THROMBOSIS 2 0.0002
277 ASPIRATION 2 0.0002
278 ASTHENOPIA 1 0.0002
279 GASTROINTESTINAL PAIN 2 0.0002
280 CHOKING SENSATION 1 0.0002
281 DENTAL CARIES 2 0.0002
282 ON AND OFF PHENOMENON 1 0.0002
283 ABNORMAL BEHAVIOUR 7 0.0002
284 PERONEAL NERVE PALSY 1 0.0002
285 IMPAIRED DRIVING ABILITY 2 0.0002
286 HYPERTONIA 1 0.0002
287 PARANOIA 3 0.0002
288 UNINTENTIONAL MEDICAL DEVICE REMOVAL 2 0.0002
289 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
290 HYPERVENTILATION 1 0.0002
291 DEVICE USE ISSUE 3 0.0002
292 HYPERKALAEMIA 6 0.0002
293 ENERGY INCREASED 1 0.0002
294 URINARY INCONTINENCE 5 0.0002
295 ATAXIA 2 0.0002
296 FALL 56 0.0002
297 CARDIAC PACEMAKER INSERTION 1 0.0002
298 WRIST FRACTURE 2 0.0002
299 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
300 TENSION 1 0.0002
301 MENISCUS INJURY 1 0.0002
302 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
303 INCOHERENT 1 0.0002
304 TENDON DISORDER 1 0.0002
305 SOMNAMBULISM 1 0.0002
306 BEDRIDDEN 2 0.0002
307 CORONAVIRUS INFECTION 1 0.0002
308 SOPOR 2 0.0002
309 ADVERSE REACTION 2 0.0002
310 MALIGNANT MELANOMA 2 0.0001
311 FREQUENT BOWEL MOVEMENTS 4 0.0001
312 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
313 RESPIRATION ABNORMAL 1 0.0001
314 DELIRIUM 5 0.0001
315 MENTAL STATUS CHANGES 4 0.0001
316 EXTRASYSTOLES 1 0.0001
317 BLOOD TEST ABNORMAL 2 0.0001
318 APPLICATION SITE REACTION 1 0.0001
319 PARALYSIS 2 0.0001
320 CEREBRAL HAEMORRHAGE 5 0.0001
321 HYPERSOMNIA 4 0.0001
322 FAECES SOFT 1 0.0001
323 APATHY 2 0.0001
324 INTENTIONAL UNDERDOSE 1 0.0001
325 MAJOR DEPRESSION 1 0.0001
326 RESTLESSNESS 5 0.0001
327 HAEMORRHAGE INTRACRANIAL 2 0.0001
328 SPEECH DISORDER 7 0.0001
329 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
330 DISSOCIATION 1 0.0001
331 BASAL CELL CARCINOMA 2 0.0001
332 AFFECTIVE DISORDER 1 0.0001
333 TREMOR 21 0.0001
334 HEAD INJURY 4 0.0001
335 RENAL CYST 1 0.0001
336 ATRIAL FLUTTER 1 0.0001
337 MOBILITY DECREASED 9 0.0001
338 METABOLIC ACIDOSIS 4 0.0001
339 BLOOD PRESSURE FLUCTUATION 3 0.0001
340 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
341 HIP FRACTURE 4 0.0001
342 FRUSTRATION TOLERANCE DECREASED 1 0.0001
343 PRESYNCOPE 3 0.0001
344 SHOCK HAEMORRHAGIC 1 0.0001
345 MANIA 2 0.0001
346 ABASIA 3 0.0001
347 HEMIPLEGIA 1 0.0001
348 RHABDOMYOLYSIS 5 0.0001
349 AGGRESSION 6 0.0001
350 GAIT INABILITY 4 0.0001
351 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
352 FACE OEDEMA 2 0.0001
353 HEMIPARESIS 2 0.0001
354 UNRESPONSIVE TO STIMULI 3 0.0001
355 ANURIA 1 0.0001
356 MULTI-ORGAN FAILURE 2 0.0001
357 DIPLOPIA 3 0.0001
358 HEAD DISCOMFORT 2 0.0001
359 GALLBLADDER DISORDER 2 0.0001
360 GASTROINTESTINAL INFECTION 1 0.0001
361 LIP DRY 1 0.0001
362 PANIC ATTACK 4 0.0001
363 BRAIN NEOPLASM 1 0.0001
364 UROSEPSIS 1 0.0001
365 NERVE COMPRESSION 1 0.0001
366 IRON DEFICIENCY ANAEMIA 1 0.0001
367 INCREASED APPETITE 2 0.0001
368 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
369 SINUS BRADYCARDIA 1 0.0001
370 DYSSTASIA 3 0.0001
371 VITAMIN D DEFICIENCY 1 0.0001
372 CHOKING 2 0.0001
373 BODY TEMPERATURE DECREASED 1 0.0001
374 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
375 BLADDER DISORDER 1 0.0001
376 TOXIC SKIN ERUPTION 1 0.0001
377 EMPHYSEMA 1 0.0001
378 EYELID PTOSIS 1 0.0001
379 DRY THROAT 1 0.0001
380 TOOTH ABSCESS 1 0.0001
381 RIB FRACTURE 2 0.0001
382 POOR VENOUS ACCESS 1 0.0001
383 WEIGHT FLUCTUATION 1 0.0001
384 DYSPHAGIA 9 0.0001
385 SCRATCH 1 0.0001
386 JOINT DISLOCATION 1 0.0001
387 RENAL PAIN 1 0.0001
388 GAIT DISTURBANCE 18 0.0001
389 URINARY TRACT INFECTION 16 0.0001
390 BODY HEIGHT DECREASED 1 0.0001
391 DECREASED ACTIVITY 1 0.0001
392 WOUND INFECTION 1 0.0001
393 EYE DISORDER 3 0.0001
394 MELAENA 2 0.0001
395 BLOOD PRESSURE DECREASED 6 0.0001
396 SYNCOPE 9 0.0001
397 URINARY RETENTION 3 0.0001
398 HYPERTENSIVE CRISIS 1 0.0001
399 MALNUTRITION 1 0.0001
400 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
401 STATUS EPILEPTICUS 1 0.0001
402 MYOCARDIAL ISCHAEMIA 1 0.0001
403 PRODUCT AVAILABILITY ISSUE 2 0.0001
404 MICTURITION URGENCY 1 0.0001
405 LETHARGY 5 0.0001
406 GASTRIC HAEMORRHAGE 1 0.0001
407 MUSCLE TWITCHING 2 0.0001
408 NIGHTMARE 3 0.0001
409 ELECTROLYTE IMBALANCE 1 0.0001
410 LOSS OF CONSCIOUSNESS 11 0.0001
411 HEART RATE DECREASED 3 0.0001
412 HYPERHIDROSIS 11 0.0001
413 CHOLECYSTITIS 1 0.0001
414 HYPERLIPIDAEMIA 1 0.0001
415 BURSITIS 1 0.0001
416 SCHIZOPHRENIA 1 0.0001
417 CEREBRAL INFARCTION 2 0.0001
418 MUSCLE SPASTICITY 1 0.0001
419 CARDIOMEGALY 1 0.0001
420 SMALL INTESTINAL OBSTRUCTION 1 0.0001
421 SPINAL OPERATION 1 0.0001
422 TENDON RUPTURE 1 0.0001
423 BALANCE DISORDER 7 0.0001
424 ILEUS 1 0.0001
425 MEMORY IMPAIRMENT 11 0.0001
426 DERMATITIS ALLERGIC 1 0.0001
427 PRODUCT COMPLAINT 2 0.0001
428 MUSCLE ATROPHY 1 0.0001
429 CARDIOVASCULAR DISORDER 2 0.0001
430 HYPOPHAGIA 2 0.0001
431 ROTATOR CUFF SYNDROME 1 0.0001
432 INFUSION SITE PAIN 1 0.0001
433 ANOREXIA 1 0.0001
434 HAEMATOMA 2 0.0001
435 NODULE 1 0.0001
436 TOOTH INFECTION 1 0.0001
437 PULMONARY CONGESTION 1 0.0001
438 DEPRESSED MOOD 4 0.0001
439 EAR INFECTION 2 0.0001
440 QUALITY OF LIFE DECREASED 1 0.0001
441 SINUS CONGESTION 1 0.0001
442 AKATHISIA 1 0.0001
443 ACUTE HEPATIC FAILURE 1 0.0001
444 CORONARY ARTERY OCCLUSION 1 0.0001
445 RESPIRATORY ARREST 2 0.0001
446 COORDINATION ABNORMAL 1 0.0001
447 DEVICE OCCLUSION 1 0.0001
448 HYPONATRAEMIA 4 0.0001
449 SINUS TACHYCARDIA 1 0.0001
450 IMPAIRED QUALITY OF LIFE 1 0.0001
451 SOMNOLENCE 14 0.0001
452 DECREASED APPETITE 16 0.0001
453 MUSCULOSKELETAL STIFFNESS 6 0.0001
454 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
455 HEPATIC FAILURE 2 0.0001
456 APHASIA 2 0.0001
457 NEPHROLITHIASIS 3 0.0001
458 MUSCULOSKELETAL CHEST PAIN 1 0.0001
459 ANKLE FRACTURE 1 0.0001
460 NERVOUS SYSTEM DISORDER 2 0.0001
461 VOMITING 30 0.0001
462 COMA 3 0.0001
463 MOOD SWINGS 2 0.0001
464 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
465 MOVEMENT DISORDER 2 0.0001
466 DRY MOUTH 5 0.0001
467 MUSCULAR WEAKNESS 7 0.0001
468 AMNESIA 4 0.0001
469 PRODUCT DOSE OMISSION 4 0.0001
470 CHOLELITHIASIS 2 0.0001
471 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
472 DRUG LEVEL INCREASED 1 0.0001
473 DEHYDRATION 8 0.0001
474 CONSTIPATION 13 0.0001
475 CELLULITIS 3 0.0001
476 ANGER 2 0.0001
477 CIRCULATORY COLLAPSE 1 0.0001
478 ASTHENIA 22 0.0001
479 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
480 ABDOMINAL PAIN UPPER 12 0.0001
481 INFLAMMATION 3 0.0001
482 MUSCULOSKELETAL DISCOMFORT 1 0.0001
483 SYRINGE ISSUE 1 0.0001
484 HYPOXIA 2 0.0001
485 HYPERTENSION 12 0.0001
486 LYMPHOCYTE COUNT DECREASED 1 0.0001
487 DRUG ERUPTION 1 0.0001
488 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
489 RESTLESS LEGS SYNDROME 1 0.0001
490 RESPIRATORY FAILURE 4 0.0001
491 HYPOTENSION 11 0.0001
492 NECK PAIN 3 0.0001
493 THINKING ABNORMAL 1 0.0001
494 DYSARTHRIA 2 0.0001
495 HYPOCALCAEMIA 1 0.0001
496 FOOT FRACTURE 1 0.0001
497 BLOOD URINE PRESENT 1 0.0001
498 DIZZINESS 26 0.0001
499 DRUG PRESCRIBING ERROR 1 0.0001
500 ACUTE RESPIRATORY FAILURE 1 0.0001
501 DYSTONIA 1 0.0001
502 ATRIAL FIBRILLATION 5 0.0001
503 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
504 NASAL CONGESTION 3 0.0001
505 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
506 UPPER LIMB FRACTURE 1 0.0001
507 INTENTIONAL SELF-INJURY 1 0.0000
508 PRODUCT ADMINISTRATION ERROR 1 0.0000
509 CONDITION AGGRAVATED 15 0.0000
510 FEEDING DISORDER 1 0.0000
511 DEVICE BREAKAGE 2 0.0000
512 OEDEMA PERIPHERAL 6 0.0000
513 PERITONITIS 1 0.0000
514 INTENTIONAL DRUG MISUSE 1 0.0000
515 DEATH 41 0.0000
516 RENAL FAILURE ACUTE 2 0.0000
517 JOINT INJURY 1 0.0000
518 WEIGHT DECREASED 13 0.0000
519 RECTAL HAEMORRHAGE 2 0.0000
520 RHINORRHOEA 3 0.0000
521 MENTAL DISORDER 2 0.0000
522 FEELING ABNORMAL 11 0.0000
523 MALAISE 20 0.0000
524 PERIPHERAL SWELLING 7 0.0000
525 LIVER DISORDER 2 0.0000
526 TACHYCARDIA 4 0.0000
527 DEVICE ISSUE 4 0.0000
528 NAUSEA 35 0.0000
529 MUSCLE SPASMS 8 0.0000
530 TINNITUS 2 0.0000
531 DIARRHOEA 28 0.0000
532 HYPOKALAEMIA 2 0.0000
533 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
534 ARRHYTHMIA 2 0.0000
535 ANXIETY 12 0.0000
536 PRODUCT PRESCRIBING ERROR 1 0.0000
537 PRODUCTIVE COUGH 2 0.0000
538 RASH ERYTHEMATOUS 2 0.0000
539 TOXICITY TO VARIOUS AGENTS 7 0.0000
540 INSOMNIA 11 0.0000
541 MENTAL IMPAIRMENT 1 0.0000
542 LUNG DISORDER 2 0.0000
543 ENCEPHALOPATHY 1 0.0000
544 VISUAL IMPAIRMENT 5 0.0000
545 ABDOMINAL PAIN LOWER 1 0.0000
546 BLOOD PRESSURE INCREASED 6 0.0000
547 ACUTE KIDNEY INJURY 6 0.0000
548 SKIN ULCER 1 0.0000
549 RASH GENERALISED 1 0.0000
550 RESPIRATORY TRACT INFECTION 1 0.0000
551 NERVOUSNESS 2 0.0000
552 DEAFNESS 1 0.0000
553 MUSCULOSKELETAL PAIN 2 0.0000
554 FEAR 1 0.0000
555 RASH PRURITIC 2 0.0000
556 OEDEMA 2 0.0000
557 LIMB INJURY 1 0.0000
558 PALLOR 1 0.0000
559 TREATMENT NONCOMPLIANCE 2 0.0000
560 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
561 VISION BLURRED 5 0.0000
562 RESPIRATORY DISTRESS 1 0.0000
563 ABNORMAL DREAMS 1 0.0000
564 TREATMENT FAILURE 3 0.0000
565 PROCEDURAL PAIN 1 0.0000
566 SEPSIS 4 0.0000
567 TARDIVE DYSKINESIA 1 0.0000
568 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
569 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
570 PAIN IN JAW 1 0.0000
571 FLATULENCE 2 0.0000
572 INTENTIONAL DOSE OMISSION 1 0.0000
573 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
574 CONVULSION 2 0.0000
575 ANGINA PECTORIS 1 0.0000
576 PRODUCT SUBSTITUTION ISSUE 2 0.0000
577 MYOCARDIAL INFARCTION 6 0.0000
578 PALPITATIONS 4 0.0000
579 ASCITES 1 0.0000
580 PRODUCT DOSE OMISSION ISSUE 10 0.0000
581 RESPIRATORY DISORDER 1 0.0000
582 ADVERSE DRUG REACTION 3 0.0000
583 JOINT SWELLING 4 0.0000
584 DISCOMFORT 2 0.0000
585 EPILEPSY 1 0.0000
586 LIMB DISCOMFORT 1 0.0000
587 FEMUR FRACTURE 1 0.0000
588 DRUG-INDUCED LIVER INJURY 1 0.0000
589 LACTIC ACIDOSIS 1 0.0000
590 IMPAIRED HEALING 1 0.0000
591 HEART RATE INCREASED 3 0.0000
592 FEBRILE NEUTROPENIA 2 0.0000
593 FUNGAL INFECTION 1 0.0000
594 NEOPLASM MALIGNANT 2 0.0000
595 ABDOMINAL DISCOMFORT 5 0.0000
596 EYE PRURITUS 1 0.0000
597 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
598 FATIGUE 23 0.0000
599 CEREBROVASCULAR ACCIDENT 5 0.0000
600 HAEMOGLOBIN DECREASED 3 0.0000
601 HAEMATURIA 1 0.0000
602 SLEEP DISORDER 2 0.0000
603 PRODUCT ADHESION ISSUE 1 0.0000
604 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
605 MYELOSUPPRESSION 1 0.0000
606 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
607 DRUG EFFECT INCOMPLETE 1 0.0000
608 ACCIDENTAL OVERDOSE 1 0.0000
609 PAIN IN EXTREMITY 8 0.0000
610 BRONCHITIS 2 0.0000
611 EYE SWELLING 1 0.0000
612 HOT FLUSH 2 0.0000
613 INTESTINAL OBSTRUCTION 1 0.0000
614 UNEVALUABLE EVENT 2 0.0000
615 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
616 HOSPITALISATION 4 0.0000
617 PYREXIA 9 0.0000
618 SEIZURE 3 0.0000
619 ABDOMINAL PAIN 6 0.0000
620 THROMBOSIS 2 0.0000
621 PSORIATIC ARTHROPATHY 1 0.0000
622 OSTEOPOROSIS 1 0.0000
623 CARDIAC ARREST 2 0.0000
624 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000
625 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
626 WITHDRAWAL SYNDROME 1 0.0000
627 RENAL IMPAIRMENT 2 0.0000
628 OSTEOARTHRITIS 1 0.0000
629 HYPOACUSIS 1 0.0000
630 DEVICE DISLOCATION 1 0.0000
631 SEPTIC SHOCK 1 0.0000
632 INTENTIONAL PRODUCT MISUSE 2 0.0000
633 COVID-19 4 0.0000
634 PRODUCT QUALITY ISSUE 3 0.0000
635 DRUG INEFFECTIVE 29 0.0000
636 SKIN IRRITATION 1 0.0000
637 SKIN DISCOLOURATION 1 0.0000
638 PNEUMONIA 7 0.0000
639 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
640 CARDIAC DISORDER 2 0.0000
641 SWELLING 2 0.0000
642 OCULAR HYPERAEMIA 1 0.0000
643 PULMONARY EMBOLISM 2 0.0000
644 NEUROPATHY PERIPHERAL 2 0.0000
645 DISEASE RECURRENCE 1 0.0000
646 MULTIPLE SCLEROSIS 1 0.0000
647 BLOOD GLUCOSE DECREASED 1 0.0000
648 DRUG INTOLERANCE 2 0.0000
649 INTERSTITIAL LUNG DISEASE 1 0.0000
650 FLUID RETENTION 1 0.0000
651 CHEST DISCOMFORT 2 0.0000
652 HEADACHE 12 0.0000
653 OFF LABEL USE 16 0.0000
654 HAEMATOCHEZIA 1 0.0000
655 ANAPHYLACTIC REACTION 1 0.0000
656 ARTHROPATHY 1 0.0000
657 THROMBOCYTOPENIA 2 0.0000
658 WEIGHT INCREASED 4 0.0000
659 OXYGEN SATURATION DECREASED 1 0.0000
660 DYSPNOEA 10 0.0000
661 MYALGIA 3 0.0000
662 DEPRESSION 4 0.0000
663 INCORRECT DOSE ADMINISTERED 4 0.0000
664 BACK PAIN 4 0.0000
665 BONE PAIN 1 0.0000
666 CHILLS 2 0.0000
667 DISEASE PROGRESSION 2 0.0000
668 WHEEZING 1 0.0000
669 CATARACT 1 0.0000
670 THERAPEUTIC RESPONSE DECREASED 1 0.0000
671 SUICIDE ATTEMPT 1 0.0000
672 VERTIGO 1 0.0000
673 NASOPHARYNGITIS 3 0.0000
674 PRURITUS 6 0.0000
675 INTENTIONAL OVERDOSE 1 0.0000
676 DEEP VEIN THROMBOSIS 1 0.0000
677 DEVICE DIFFICULT TO USE 1 0.0000
678 RENAL FAILURE 2 0.0000
679 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
680 ARTHRALGIA 6 0.0000
681 COUGH 4 0.0000
682 BURNING SENSATION 1 0.0000
683 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
684 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
685 OVERDOSE 3 0.0000
686 INFECTION 2 0.0000
687 DYSGEUSIA 1 0.0000
688 EPISTAXIS 1 0.0000
689 CHRONIC KIDNEY DISEASE 1 0.0000
690 DIABETES MELLITUS 1 0.0000
691 INJECTION SITE SWELLING 1 0.0000
692 PAIN 8 0.0000
693 ARTHRITIS 1 0.0000
694 PARAESTHESIA 2 0.0000
695 CARDIAC FAILURE 1 0.0000
696 CARDIAC FAILURE CONGESTIVE 1 0.0000
697 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
698 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
699 GASTROINTESTINAL DISORDER 1 0.0000
700 ADVERSE EVENT 1 0.0000
701 OROPHARYNGEAL PAIN 1 0.0000
702 CHEST PAIN 2 0.0000
703 ANAEMIA 2 0.0000
704 CONTUSION 1 0.0000
705 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
706 FLUSHING 1 0.0000
707 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
708 SINUSITIS 1 0.0000
709 ERYTHEMA 2 0.0000
710 ILLNESS 1 0.0000
711 ABDOMINAL DISTENSION 1 0.0000
712 HAEMORRHAGE 1 0.0000
713 PLATELET COUNT DECREASED 1 0.0000
714 INFLUENZA 1 0.0000
715 ASTHMA 1 0.0000
716 INJECTION SITE ERYTHEMA 1 0.0000
717 RASH 3 0.0000
718 HYPOAESTHESIA 1 0.0000
719 URTICARIA 1 0.0000
720 HYPERSENSITIVITY 1 0.0000
721 PRODUCT USE ISSUE 1 0.0000
722 BLOOD GLUCOSE INCREASED 1 0.0000
723 ALOPECIA 1 0.0000